Skip to content

This is an observational study conducted to observe how subjects with dizziness and dizziness associated symptoms are managed in primary care setting in India.

A multicenter, non-interventional, observational registry to determine clinicoepidemiological profile and management practices of dizziness in primary care setting in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/11/016408
Enrollment
1000
Registered
2018-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G89-G99- Other disorders of the nervous system

Interventions

None listed

Sponsors

Abbott Healthcare Private Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult male and female patients (aged >=18 years) presenting with dizziness in primary care 2. Patients willing to participate in the registry and provide informed consent for participation 3. Patients who are willing and competent to sign and date a patient authorization form (PAF) for participation in the study

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women 2. Patients with dizziness requiring hospitalization for any cause 3. Any condition that in the opinion of the investigator does not justify the patientâ??s inclusion in the study

Design outcomes

Primary

MeasureTime frame
To determine clinicoepidemiological profile of patients presenting with dizziness in the primary care setting Timepoint: 1. Base to Week 1 2. Baseline to Week4

Secondary

MeasureTime frame
Management practices a. Number and percentage of patients advised to undergo routine assessments/advanced assessments b. Number and percentage of patients being advised lifestyle modification (change in smoking habit/alcohol consumption/diet/exercise/both), and/or pharmacotherapy (betahistine, prochlorperazine and cinnarizine monotherapy, and cinnarizine fixed dose combination therapy) and/or referred to specialists for further managementTimepoint: Number and percentage of patients advised for advanced assessment or lifestyle modification -From 1. Baseline to week1 , 2. Week1 and week4.

Countries

India

Contacts

Public ContactSneha Nair

RKK Medical Center

drrkkgp@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 16, 2026